We have maintained a constant association with and vocation for clinical epidemiology studies. This has allowed us to link the sponsorship VALUE offered by the pharmaceutical sector with leading research initiatives. It has also allowed us to establish important strategic links with scientific companies and health institutions.
Under regular clinical practice conditions, obtaining the in vitro allergic sensitisation profile in patients with seasonal allergic rhinitis and in vivo double sensitisation to olive and grassy pollens.
Asthma and chronic obstructive pulmonary disease (COPD) are some of the most significant public health problems due to their high prevalence and morbidity-mortality, resulting in high socio-economic costs. These diseases can co-exist and when they do so, this patient population is often excluded from clinical trials with medicines..
Epidemiology and eHealth in prevention and diagnosis
Record of ECGs digitised by the ELECTROPRES platform that allows the early detection of left ventricular hypertrophy (LVH) from different measurement methods widely validated in international literature. (>8,500 ECG; 62 PC centres in 13 autonomous communities).
MAPAPRES and AMPAPRES records have allowed a more in-depth knowledge of isolated clinical hypertension both in patients with or without antihypertensive treatment, the variability of blood pressure, risk groups and their clinical implications, circadian pattern, or resistant hypertension. (>1,000 doctors nearly 150,000 patients).